NCT00104923 2017-07-19Fenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerCalifornia Cancer ConsortiumPhase 1 Completed29 enrolled
NCT00387504 2013-09-12Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCalifornia Cancer ConsortiumPhase 1 Completed21 enrolled